Basic Information
Basic information for SNHG14-270-33aa-1
Peptide Name SNHG14-270-33aa-1
Genome Position chr15:25098737-25098828,25099145-25099151[+]
Species Human
Peptide Sequence MEFHCQTSEVLILTFVPANVAVKKHTNTLLRTA
Peptide Length 33
Unique No (SNHG14-208-33aa-1,SNHG14-210-33aa-1,SNHG14-216-33aa-2,SNHG14-224-33aa-2,SNHG14-227-33aa,SNHG14-230-33aa,SNHG14-231-33aa,SNHG14-232-33aa,SNHG14-235-33aa,SNHG14-236-33aa,SNHG14-239-33aa,SNHG14-242-33aa,SNHG14-248-33aa-2,SNHG14-249-33aa,SNHG14-254-33aa,SNHG14-255-33aa,SNHG14-257-33aa,SNHG14-263-33aa,SNHG14-268-33aa,SNHG14-269-33aa-1,SNHG14-272-33aa-2,SNHG14-274-33aa,SNHG14-275-33aa,SNHG14-276-33aa,SNHG14-277-33aa,SNHG14-278-33aa,SNHG14-279-33aa,SNHG14-280-33aa,SNHG14-281-33aa,SNHG14-282-33aa-2,SNHG14-283-33aa,SNHG14-287-33aa,SNHG14-288-33aa,SNHG14-290-33aa,SNHG14-291-33aa-2,SNHG14-297-33aa-1,SNHG14-298-33aa,SNHG14-299-33aa-1,SNHG14-300-33aa,SNHG14-301-33aa,SNHG14-303-33aa,SNHG14-304-33aa,SNHG14-305-33aa,SNHG14-307-33aa,SNHG14-309-33aa-2,SNHG14-310-33aa,SNHG14-311-33aa,SNHG14-312-33aa,SNHG14-313-33aa,SNHG14-314-33aa,SNHG14-315-33aa-1,SNHG14-316-33aa,SNHG14-318-33aa,SNHG14-319-33aa,SNHG14-321-33aa,SNHG14-323-33aa-2,SNHG14-324-33aa-1,SNHG14-325-33aa,SNHG14-332-33aa,SNHG14-333-33aa-1,SNHG14-334-33aa,SNHG14-339-33aa,SNHG14-340-33aa)
Grand Average of Hydropathicity 0.297
Relative Molecular Mass 4290.04
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000660956;SNHG14-270
Transcript Length 13199
Coding Ability 0.3864
DNA Sequence Corresponding to Peptide ATGGAATTTCATTGCCAAACCAGTGAAGTGCTAATTTTGACATTTGTACCAGCTAACGTAGCTGTGAAGAAACACACCAATACACTTCTAAGGACAGCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :